Latest 30 News in the Life Sciences Industry
GlobeNewswire
RECORDATI CELEBRATES ITS FIRST 100 YEARS AT TRIENNALE MILANO WITH AN EXHIBITION REVEALING OBJECTS AND IMAGES FROM ITS HISTORICAL ARCHIVE FOR THE FIRST TIME
16 Jun 2026
PR Newswire Association LLC.
Tethis announces application note of SmartBioSurface® slides for cell suspension workflows on leading spatial biology platform
15 Jun 2026
GlobeNewswire
EURneffy 1 mg approved in the UK as the first and only needle-free adrenaline treatment for young children (aged 4 and older, 15–30 kg) at risk of anaphylaxis
15 Jun 2026
GlobeNewswire
Novartis RemIND data at EAACI show Rhapsido® potential as first targeted therapy for chronic inducible urticaria (CIndU)
12 Jun 2026
GlobeNewswire
Anaphylaxis management is falling short in 2026 – EAACI data suggest EURneffy, the only needle-free nasal adrenaline spray, could help close the gap
11 Jun 2026
GlobeNewswire
Novartis delpacibart braxlosiran (del-brax) Phase I/II study in facioscapulohumeral muscular dystrophy (FSHD) meets primary biomarker endpoint
11 Jun 2026
GlobeNewswire
Italfarmaco Announces Health Canada Acceptance and Priority Review of New Drug Submission for Givinostat as a Duchenne Muscular Dystrophy Treatment
10 Jun 2026
PR Newswire Association LLC.
Tethis to launch SmartBioSurface® slides at EACR Conference
08 Jun 2026
GlobeNewswire
Novartis to highlight Rhapsido® data across multiple immune-mediated diseases at EAACI Congress 2026
08 Jun 2026
GlobeNewswire
Boehringer Ingelheim’s survodutide Phase III trial showed targeted 34% visceral and 63% liver fat reduction, while minimizing lean mass loss in pre-specified analysis, supporting improved metabolic health in people living with obesity
07 Jun 2026
GlobeNewswire
Novartis IgAN data in The Lancet show clinically meaningful slowing of kidney function decline with Vanrafia® over 2.5 years
04 Jun 2026
GlobeNewswire
ALK will present data on real world-use of nasal adrenaline and key learnings from 20 years with SLIT-tablets at EAACI 2026
04 Jun 2026
GlobeNewswire
Novartis Cosentyx® PMR data in New England Journal of Medicine showed sustained remission vs placebo in twice as many patients
03 Jun 2026
GlobeNewswire
Angelini Ventures Marks First Portfolio Company Exit as ResMed Acquires Noctrix Health for $340 million
03 Jun 2026
GlobeNewswire
Nouscom Receives U.S. FDA Fast Track Designation for NOUS-209, a Novel Immunotherapy for the Prevention of Lynch Syndrome-Associated Cancers
01 Jun 2026
PR Newswire Association LLC.
STAR Network Foundation Named Sponsor of Global Summit 2026: Fostering Hope for Children
01 Jun 2026
GlobeNewswire
Scemblix® continued to show superior efficacy and favorable safety and tolerability profile at week 144 in newly diagnosed CML
01 Jun 2026
GlobeNewswire
Report on transactions with ALK-Abelló A/S B shares and associated securities by managerial staff
01 Jun 2026
PR Newswire Association LLC.
Parkinson's Foundation & WHO Foundation Announce Partnership to Advance Global Care
09 Jun 2026
PR Newswire Association LLC.
ANTARES VISION GROUP DEBUTS LASER SPECTROSCOPY LEAK DETECTION TECHNOLOGY AT PROPAK ASIA 2026
09 Jun 2026
PR Newswire Association LLC.
UPMC Italy and United Imaging Healthcare bring Europe's first CE-marked uRT-linac 506c to Italy
29 May 2026
PR Newswire Association LLC.
Menarini Group Announces New Data at the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting
25 May 2026
PR Newswire Association LLC.
Gene Solutions Showcases AI-Powered Multi-Omics Liquid Biopsy Innovations at TJCC 2026: Advancing Precision Oncology in Taiwan
22 May 2026
PR Newswire Association LLC.
In Honor of Mental Health Awareness Month, Wellness Experts Dr. Desi Bartlett and Ilanit Blumenfeld, MPH, RDN, CDN, Announce Transformational Tuscany Retreat
19 May 2026
PR Newswire Association LLC.
Bracco and ACIST Medical Systems Announce U.S. FDA Clearance of ACIST Pro™ Diagnostic System
18 May 2026
PR Newswire Association LLC.
Lundbeck receives orphan drug designation in Japan for asedebart for the treatment of patients with congenital adrenal hyperplasia and Cushing's disease
18 May 2026
PR Newswire Association LLC.
Shaman Launches Shaman Atlas to Convert Pharma's Approved Content Into Structured Data
18 May 2026
PR Newswire Association LLC.
ESGE Days 2026: Endoscopic procedure associated with greater short-term weight loss than oral semaglutide, study finds
15 May 2026
Latest News All News
Upcoming Events All Events
- June 2026
- San Diego: RESI San Diego 2026
- San Diego: BIO 2026
- July 2026
- Taipei: BIO Asia-Taiwan